Immunovia AB Profit Margin

The latest profit margin for IMMVF is -7287.72% as of June 2026. That compares with -15978.35% in the prior-year period — up 54.4% year over year. That is below the sector sector average of 13.16%. Investors often review this figure alongside Immunovia AB's historical trend and sector peers before judging valuation or financial health.

Over the past year, IMMVF's profit margin moved from -15978.35% to -7287.72% — a 54.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Immunovia AB's valuation or profitability profile.

Against its sector companies, IMMVF currently prints -7287.72% for profit margin, while the sector average sits near 13.16%. That is roughly 55463.1% below the sector mean. Large gaps often invite a closer look at Immunovia AB's growth, margins, and balance sheet.

Profit Margin shows how effectively Immunovia AB converts resources into returns. At -7287.72%, IMMVF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -15978.35% in the prior-year period — up 54.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting IMMVF's profit margin (-7287.72%), review year-over-year change from -15978.35%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.